Catheter Precision financials
$0.1467−4.55%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $432.0K | $238.0K | $226.0K | $212.0K | $143.0K | $149.0K | $96.0K | $93.0K | $82.0K | $128.0K | $133.0K |
| Gross profit | $98.0K | $390.0K | $218.0K | $208.0K | $198.0K | $132.0K | $138.0K | $86.0K | $77.0K | $77.0K | $121.0K | $127.0K |
| Gross margin | 9.6% | 90.3% | 91.6% | 92.0% | 93.4% | 92.3% | 92.6% | 89.6% | 82.8% | 93.9% | 94.5% | 95.5% |
| Operating income | -$4.0M | -$2.3M | -$2.9M | -$3.0M | -$4.7M | -$3.6M | -$3.1M | -$2.9M | -$2.7M | -$2.6M | -$2.6M | -$2.7M |
| Net income | -$2.6M | -$3.0M | -$5.8M | -$2.3M | -$5.1M | -$4.0M | -$10.8M | -$4.1M | -$4.2M | -$2.7M | -$669.0K | -$1.9M |
| Net margin | −250.7% | −703.9% | −2427.7% | −996.0% | −2409.9% | −2828.7% | −7238.9% | −4291.7% | −4537.6% | −3262.2% | −522.7% | −1448.9% |
| Diluted EPS | $-0.92 | $-1.39 | $-3.39 | $-1.70 | $-7.28 | $-6.81 | $-17.90 | $-38.17 | $-105.83 | $-68.40 | $-7.05 | $-53.77 |
| EBITDA | -$3.6M | -$1.9M | -$2.3M | -$2.5M | -$4.2M | -$3.0M | -$2.5M | -$2.3M | -$2.2M | -$2.1M | -$2.6M | -$2.2M |
| Operating cash flow | -$2.9M | -$2.8M | -$1.5M | -$2.2M | -$2.3M | -$2.3M | -$2.9M | -$2.8M | -$1.7M | -$1.9M | -$1.9M | -$1.8M |
| Free cash flow | -$2.9M | -$2.8M | -$1.5M | -$2.2M | -$2.3M | -$2.3M | -$2.9M | -$2.8M | -$1.7M | -$2.0M | -$1.9M | -$1.8M |
| Diluted shares | 2.8M | 2.2M | 1.7M | 1.3M | 0.7M | 0.6M | 0.6M | 0.1M | 0.0M | 0.0M | 0.1M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $643.0K | $441.0K | $88.0K | $1.1M | $838.0K | $450.0K |
| Short-term investments | $1.2M | $0.00 | $0.00 | $981.0K | $874.0K | $0.00 |
| Total debt | $10.3M | $10.4M | $3.4M | $1.3M | $1.3M | $1.7M |
| Total assets | $36.9M | $35.1M | $15.9M | $25.5M | $25.6M | $24.8M |
| Total liabilities | $19.7M | $25.9M | $9.2M | $19.0M | $19.0M | $16.9M |
| Shareholders' equity | $17.1M | $9.2M | $6.7M | $6.4M | $6.5M | $7.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology